SCHEMBL736859

SCHEMBL736859

CC(C)(N)C(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1cccc2ccccc12)NC=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.60
OPRM1 P35372 1/20 0.60
CTSS P25774 3/20 0.41
CTSK P43235 3/20 0.41
CTSB P07858 2/20 0.41
MMP9 P14780 2/20 0.41
MMP8 P22894 2/20 0.41
MME P08473 4/20 0.41
ACE P12821 4/20 0.41
CPA1 P15085 3/20 0.41
ACE2 Q9BYF1 3/20 0.41
PSMB8 P28062 1/20 0.40
PSMB5 P28074 1/20 0.40
CTSL P07711 1/20 0.40
PIN1 Q13526 2/20 0.39
MC4R P32245 1/20 0.39
MC3R P41968 1/20 0.39
MC1R Q01726 1/20 0.39
MMP14 P50281 1/20 0.39
OPRD1 P41143 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL736857 0.96 GHSR (0.60) GHSROPRM1CTSSCTSKCTSB
SCHEMBL737881 0.91 OPRM1 (0.57) GHSROPRM1CTSSCTSKCTSB
SCHEMBL736941 0.91 GHSR (0.71) GHSROPRM1CTSSCTSKMMP9
SCHEMBL736985 0.88 GHSR (0.56) GHSROPRM1CTSSCTSKCTSB
SCHEMBL737877 0.87 GHSR (0.81) GHSROPRM1ACEMC4RMC3R
SCHEMBL737824 0.84 GHSR (0.56) GHSROPRM1CTSSCTSKCTSB
SCHEMBL737619 0.84 GHSR (0.81) GHSROPRM1ACEMC4RMC3R
SCHEMBL736854 0.83 GHSR (0.61) GHSROPRM1CTSSCTSKMMP9
SCHEMBL736946 0.83 GHSR (0.61) GHSROPRM1CTSSCTSKMMP9
SCHEMBL737074 0.82 GHSR (0.88) GHSROPRM1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138218-B2 Growth hormone secretagogues IPSEN PHARMA S.A.S. (FR) 2012-03-20 US disclosed
US-20090131478-A1 Growth Hormone Secretagogues IPSEN PHARMA S.A.S. (FR) 2009-05-21 US disclosed
WO-2007014258-A2 GROWTH HORMONE SECRETAGOGUES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) 2007-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131478-A1 Growth Hormone Secretagogues GHSR, GHRHR, GHITM GHSR 1/4885OPRM1 3398/4885CTSS 886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.